Neovatus Health Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 548.72%
- Profit Growth 1289.57%
- Ebitda -126.69%
- Net Worth 477.09%
- Total Assets 7.91%
About Neovatus Health Solutions
Neovatus Health Solutions Private Limited (NHSPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 October 2019 (Five years and three months 18 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Umesh Singh, Namrata Singh, and Anand Srivastava serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2019PTC356711
-
Company No.
356711
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Oct 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Neovatus Health Solutions?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Singh
|
Director | 25-Oct-2019 | Current |
|
Namrata Singh
|
Director | 25-Oct-2019 | Current |
|
Anand Srivastava
|
Director | 29-Jan-2022 | Current |
Financial Performance of Neovatus Health Solutions.
Neovatus Health Solutions Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 548.72% increase. The company also saw a substantial improvement in profitability, with a 1289.57% increase in profit. The company's net worth Soared by an impressive increase of 477.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neovatus Health Solutions?
In 2020, Neovatus Health Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rvl Scientific & Engineering Private LimitedUmesh Singh is a mutual person
-
Rupas Biological Private LimitedUmesh Singh is a mutual person
-
Anandmai Kosh Private Limited
Umesh Singh and Anand Srivastava are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neovatus Health Solutions?
Unlock and access historical data on people associated with Neovatus Health Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neovatus Health Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neovatus Health Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.